Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FHY6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,266
Award facts
- Contract value 100% obligated
- $15,265.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $15,265.71. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company has established itself through numerous competitively awarded contracts with the Defense Logistics Agency, supplying a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. Dupixent is a specialty biologic medication used primarily for treating moderate-to-severe eczema, asthma, and other allergic conditions, reflecting AmerisourceBergen's role in delivering advanced pharmaceutical therapies to support Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FHY6X?
SPE2DR26FHY6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FHY6X worth?
The government has obligated $15,266 on SPE2DR26FHY6X.
Is contract SPE2DR26FHY6X an order under another contract?
Yes. SPE2DR26FHY6X is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY6X competed?
The extent of competition for SPE2DR26FHY6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award